Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jose M. Pacheco

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 Mg in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

Frontiers in Oncology

Cancer Research

English

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-Small Cell Lung Cancer

Frontiers in Oncology

Cancer Research

English

Related publications

Osimertinib 160 Mg Daily for Advanced Non‐small Cell Lung Cancer With Leptomeningeal Metastasis: A Case Report

Asia-Pacific Journal of Clinical Oncology

English

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

Cancer Research

English

Overcoming T790M Mutant Small Cell Lung Cancer With the Third-Generation EGFR-TKI Osimertinib

Thoracic Cancer

Respiratory Medicine

English

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-mutant Non-Small Cell Lung Cancer Cells

Molecular Cancer Research

Cancer Research

Molecular Biology

English

P1.01-47 Phase I/Ii Trial of Dasatinib and Osimertinib in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-95 EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.13-42 Osimertinib Treatment for Patients With EGFR Exon 20 Insertion Positive Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Osimertinib (AZD9291) Increases Radio‑sensitivity in EGFR T790M Non‑small Cell Lung Cancer

Oncology Reports

Cancer Research

English

Spatiotemporal T790M Heterogeneity in a Patient With EGFR-Mutant Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English